# A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy

> **NCT02201251** · PHASE3 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 63 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Topiramate
- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT02201251
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-06
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201251, "A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02201251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*